Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-provides-safety-and-functional-update-on-its-phase-11b-101-trial-and-its-phase-2-ikt-148009-201-trial-in-parkinsons-disease-301807589.html
Apr 26, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next